跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
章 宏吉
主治醫師
,
衛生福利部雙和醫院
https://orcid.org/0000-0001-7430-120X
電子郵件
09331
s.tmu.edu
tw
h-index
91
引文
4
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2022
每年研究成果
概覽
指紋
網路
研究成果
(11)
類似的個人檔案
(7)
指紋
查看啟用 Hung-Chi Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Sex Difference
100%
Anesthesiologist
57%
Kidney Transplantation
50%
Randomized Controlled Trial
50%
Sevoflurane
50%
Catheter Ablation
50%
Epidural
50%
Pediatrics
50%
4 Iodo 2,5 Dimethoxyamphetamine
50%
Desflurane
50%
Recurrent Disease
50%
Renal Replacement Therapy
50%
Heart Surgery
50%
Atrial Fibrillation
50%
Levobupivacaine
50%
Electrocardiogram
50%
Odds Ratio
50%
Consciousness Level
50%
Analgesia
50%
Smooth Muscle
50%
Cesarean Section
50%
Fentanyl
50%
Electroencephalogram
50%
Dexmedetomidine
50%
Lupus Erythematosus
50%
Central Venous Catheter
50%
Hemodialysis
44%
Depth of Anesthesia
33%
End Stage Renal Disease
27%
Peritoneal Dialysis
27%
Bispectral Index
25%
Lupus Nephritis
22%
Anesthetic Agent
20%
Adverse Event
18%
Survival Rate
16%
Urinary Tract Infection
16%
Epidural Patient-Controlled Analgesia
14%
Anodyne
14%
Extubation
12%
Operating Room
12%
Cardiopulmonary Bypass
12%
Clinician
12%
Transesophageal Echocardiography
12%
Brachiocephalic Vein
12%
Trachea
12%
Methacholine
12%
General Anesthesia
12%
Arteriovenous Fistula
11%
Hospital Mortality
11%
Research Equipment
8%
Pharmacology, Toxicology and Pharmaceutical Science
Levobupivacaine
100%
Urinary Tract Infection
56%
Replacement Therapy
50%
Epidural
50%
Recurrent Disease
50%
Randomized Controlled Trial
50%
Duragesic
50%
Hospital Mortality
50%
Hemodialysis
50%
Atrial Fibrillation
50%
Desflurane
50%
Dexmedetomidine
50%
Sevoflurane
50%
Adverse Event
38%
End Stage Renal Disease
31%
Lupus Erythematosus Nephritis
25%
Acute Heart Infarction
25%
Septicemia
25%
Wound Infection
25%
Mortality Rate
25%
Acute Kidney Failure
25%
Methacholine
23%
Survival Rate
18%
Analgesic Agent
14%
Anesthetic Agent
12%
Arteriovenous Fistula
12%
Opiate
7%
Delayed Release
6%
Infection
6%
Number Needed to Treat
6%
Spasmolytic Agent
6%
Onset Age
6%
Adrenergic Receptor Stimulating Agent
6%
Emergence Agitation
6%
Peritonitis
6%
Sepsis
6%
Cholinergic Receptor
5%
Bupivacaine
5%
